Important new therapies for methicillin-resistant Staphylococcus aureus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Important new therapies for methicillin-resistant Staphylococcus aureus
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 20, Issue 18, Pages 2317-2334
Publisher
Informa UK Limited
Online
2019-10-18
DOI
10.1080/14656566.2019.1675637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceftaroline-Associated Neutropenia: Case Series and Literature Review of Incidence, Risk Factors, and Outcomes
- (2019) Eva L Sullivan et al. Open Forum Infectious Diseases
- The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
- (2019) Shen-Peng Chang et al. Infection and Drug Resistance
- Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase
- (2019) Elizabeth G. Gibson et al. ACS Infectious Diseases
- Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
- (2019) James A. McKinnell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline for Community-Acquired Bacterial Pneumonia
- (2019) Roman Stets et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
- (2019) William O’Riordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Solithromycin monotherapy for treatment of community‐acquired bacterial pneumonia: A meta‐analysis of randomised controlled trials
- (2019) Junlin Wen et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Eravacycline: A Review in Complicated Intra-Abdominal Infections
- (2019) Lesley J. Scott DRUGS
- Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015–2016)
- (2019) Susanne Paukner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2019) Matthew Geriak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1 Study
- (2019) J. Scott Overcash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
- (2019) Philip A Giordano et al. CLINICAL INFECTIOUS DISEASES
- Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft tissue infections
- (2019) Edit Urbán et al. CLINICAL MICROBIOLOGY AND INFECTION
- Real world use of Telavancin in the treatment of osteomyelitis
- (2019) Louis D. Saravolatz et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The safety of treatment options for acute bacterial skin and skin structure infections
- (2019) Matteo Bassetti et al. Expert Opinion On Drug Safety
- Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis
- (2019) Tanaya Bhowmick et al. INFECTION
- Prediction of lefamulin epithelial lining fluid penetration after intravenous and oral administration using Phase 1 data and population pharmacokinetics methods
- (2019) Li Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae
- (2019) Wolfgang W Wicha et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China
- (2019) Chunjiang Zhao et al. BMC INFECTIOUS DISEASES
- Novel developments in the treatment of acute bacterial skin and skin structure infections
- (2019) Rupal K. Jaffa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Control of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses
- (2019) Kevin T. Kavanagh Antimicrobial Resistance and Infection Control
- The Efficacy and Safety of Eravacycline in the Treatment of Complicated Intra-Abdominal Infections: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
- (2019) Shao-Huan Lan et al. Journal of Clinical Medicine
- Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
- (2019) Shao-Huan Lan et al. Journal of Clinical Medicine
- A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)
- (2018) Thomas L. Holland et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese Adults
- (2018) Caiyun Zhao et al. CLINICAL THERAPEUTICS
- The role of dalbavancin in skin and soft tissue infections
- (2018) Matteo Bassetti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe
- (2018) David B. Huang et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering
- (2018) Matteo Bassetti et al. Future Microbiology
- Dalbavancin in the treatment of different gram-positive infections: a real-life experience
- (2018) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Lefamulin: Review of a promising novel pleuromutilin antibiotic
- (2018) Michael P. Veve et al. PHARMACOTHERAPY
- A live vaccine to Staphylococcus aureus infection
- (2018) Dane Parker Virulence
- A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus
- (2018) Miriam Moscoso et al. Virulence
- Iclaprim: a differentiated option for the treatment of skin and skin structure infections
- (2018) Stephanie Noviello et al. Expert Review of Anti-Infective Therapy
- Treatment of chronic osteomyelitis with multi-dose oritavancin: a case series and literature review
- (2018) Daniel B. Chastain et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Plazomicin: A Next-Generation Aminoglycoside
- (2018) Kristy M. Shaeer et al. PHARMACOTHERAPY
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
- (2018) Urania Rappo et al. Open Forum Infectious Diseases
- Espectro antimicrobiano de dalbavancina. Mecanismo de acción y actividad in vitro frente a microorganismos Gram positivos
- (2017) Emilia Cercenado ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Actividad comparativa de tedizolid frente a Staphylococcus coagulasa negativos resistentes a linezolid y Staphylococcus aureus resistentes a meticilina
- (2017) Santiago Pérez-Parra et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections
- (2017) Darrell McBride et al. Expert Opinion on Drug Metabolism & Toxicology
- In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
- (2017) María Carmen López Díaz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new
- (2017) Michael Z. David et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age
- (2017) Daniel Gonzalez et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review
- (2017) Reese A. Cosimi et al. Open Forum Infectious Diseases
- Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe
- (2017) R Köck et al. Eurosurveillance
- A Pathogen-Selective Antibiotic Minimizes Disturbance to the Microbiome
- (2016) Jiangwei Yao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens
- (2016) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin Against Gram-Positive Organisms Using Data From Murine Infection Models
- (2016) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
- (2016) Antonio Torres et al. CLINICAL PHARMACOKINETICS
- Ceftobiprole medocaril (BAL-5788) for the treatment of complicated skin infections
- (2016) Amelia N. Deitchman et al. Expert Review of Anti-Infective Therapy
- Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy
- (2016) Chiara Oltolini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-Infective
- (2016) Regis P. Kowalski et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us
- (2016) Eric F. Kong et al. PLoS Pathogens
- Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort
- (2016) Kimberly G. Blumenthal et al. Journal of Allergy and Clinical Immunology-In Practice
- Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
- (2016) Travis Jones et al. Infection and Drug Resistance
- Community-Associated Methicillin-ResistantStaphylococcus aureusin a Pediatric Emergency Department in Newfoundland and Labrador
- (2016) Erin Peebles et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment
- (2015) Brian D. Jamieson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia
- (2015) Ko-Hung Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities
- (2015) B. Hafkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
- (2015) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
- (2015) Michael W. Dunne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin: A Long-Half-Life Lipoglycopeptide
- (2015) Louis D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Risk Factors for Invasive Methicillin-ResistantStaphylococcus aureusInfection After Recent Discharge From an Acute-Care Hospitalization, 2011–2013
- (2015) Lauren Epstein et al. CLINICAL INFECTIOUS DISEASES
- Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review
- (2015) Françoise Van Bambeke DRUGS
- Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
- (2015) George G. Zhanel et al. DRUGS
- Dalbavancin for the treatment of acute bacterial skin and skin structure infections
- (2015) Sheena Ramdeen et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function
- (2015) A. Canut et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae
- (2015) Wonhee So et al. JOURNAL OF UROLOGY
- Pharmacokinetics, Safety and Tolerability of Single Dose Dalbavancin in Children 12–17 Years of Age
- (2015) John S. Bradley et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial
- (2015) Chin Kook Rhee et al. International Journal of Chronic Obstructive Pulmonary Disease
- Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women
- (2014) Kevin P. Connors et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16
- (2014) Bruk Mensa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
- (2014) Andrew F. Shorr et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin against Biofilms from Staphylococcus aureus Clinical Isolates
- (2014) Wafi Siala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
- (2014) Martin E Stryjewski et al. BMC INFECTIOUS DISEASES
- Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
- (2014) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
- (2014) S. S. Awad et al. CLINICAL INFECTIOUS DISEASES
- Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus
- (2014) G. R. Corey et al. CLINICAL INFECTIOUS DISEASES
- New epidemiology of Staphylococcus aureus infection in Asia
- (2014) C.-J. Chen et al. CLINICAL MICROBIOLOGY AND INFECTION
- A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic?
- (2014) E. Drougka et al. CLINICAL MICROBIOLOGY AND INFECTION
- Nemonoxacin: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
- (2014) K. E. Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
- (2014) G. Ralph Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Biofilm Formation between Major Clonal Lineages of Methicillin Resistant Staphylococcus aureus
- (2014) Evelyn Vanhommerig et al. PLoS One
- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
- (2013) David Oldach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro,In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
- (2013) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Safety Summary
- (2013) D. Das et al. CLINICAL INFECTIOUS DISEASES
- Current and prospective treatments for multidrug-resistant gram-positive infections
- (2013) Jeffrey M Rybak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada
- (2013) K. A. Nichol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
- (2013) Mary A Banevicius et al. JOURNAL OF CHEMOTHERAPY
- Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
- (2013) Shawn D. Flanagan et al. PHARMACOTHERAPY
- Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus in the United States: A Meta-Analysis
- (2013) Vanja M. Dukic et al. PLoS One
- MRSA in Africa: Filling the Global Map of Antimicrobial Resistance
- (2013) Matthew E. Falagas et al. PLoS One
- Mode of Action,In VitroActivity, andIn VivoEfficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
- (2012) Nachum Kaplan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects
- (2012) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent development of potent analogues of oxazolidinone antibacterial agents
- (2012) Katarzyna Michalska et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
- (2012) Rodrigo E. Mendes et al. CLINICAL INFECTIOUS DISEASES
- Executive Summary: Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
- (2012) Douglas R. Osmon et al. CLINICAL INFECTIOUS DISEASES
- Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the ‘creeps’?
- (2012) Adrian J. Brink Current Opinion in Critical Care
- Summary of Pharmacokinetics and Tissue Distribution of a Broad-Spectrum Fluoroquinolone, JNJ-Q2
- (2012) J. M. Davenport et al. Clinical Pharmacology in Drug Development
- The Chemistry of Peptidyltransferase Center-Targeted Antibiotics: Enzymatic Resistance and Approaches to Countering Resistance
- (2011) Kevin P. McCusker et al. ACS Chemical Biology
- Evaluation of Ceftobiprole Activity against a Variety of Gram-Negative Pathogens, Including Escherichia coli, Haemophilus influenzae (β-Lactamase Positive and β-Lactamase Negative), and Klebsiella pneumoniae, in a Rabbit Meningitis Model
- (2011) A. Stucki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
- (2011) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia
- (2011) M. Bassetti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Veterans Affairs Initiative to Prevent Methicillin-ResistantStaphylococcus aureusInfections
- (2011) Rajiv Jain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations
- (2010) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
- (2010) D. J. J. van Rensburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of the Investigational Fluoroquinolone Finafloxacin against Ciprofloxacin-Sensitive and -Resistant Acinetobacter baumannii Isolates
- (2010) P. G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice
- (2010) M. Dryden et al. CLINICAL MICROBIOLOGY AND INFECTION
- Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
- (2010) M. Z. David et al. CLINICAL MICROBIOLOGY REVIEWS
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Type IIA topoisomerase inhibition by a new class of antibacterial agents
- (2010) Benjamin D. Bax et al. NATURE
- Ceftobiprole
- (2009) George G Zhanel et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- In Vitro Bactericidal Activity of Iclaprim in Human Plasma
- (2009) H. Laue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole
- (2009) K. A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II
- (2009) C. S. Lunde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Classification of Staphylococcal Cassette Chromosome mec (SCCmec): Guidelines for Reporting Novel SCCmec Elements
- (2009) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus
- (2009) P. Tattevin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Topical Therapy for Methicillin-Resistant Staphylococcus aureus Colonization Impact on Infection Risk
- (2009) Ari Robicsek et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity
- (2009) C. Oefner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of SCCmecType IV and SCCmecType V Methicillin-ResistantStaphylococcus aureusContaining the Panton-Valentine Leukocidin Genes in a Large Academic Teaching Hospital in Central Switzerland: External Invaders or Persisting Circulators?
- (2009) Giorgia Valsesia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
- (2009) Thomas Marbury et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004–2007)
- (2009) S. Thibaut et al. MEDECINE ET MALADIES INFECTIEUSES
- De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
- (2009) S. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
- (2008) L. Lawrence et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
- (2008) G. J. Noel et al. CLINICAL INFECTIOUS DISEASES
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Community-Associated Methicillin-Resistant Staphylococcus aureus
- (2008) Thomas R. Wallin et al. EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
- Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase
- (2008) C. A. Arias et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Staphylococcus aureus in Dermatology Outpatients with Special Emphasis on Community-Associated Methicillin-Resistant Strains
- (2008) Uta Jappe et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increase in a Dutch Hospital of Methicillin-Resistant Staphylococcus aureus Related to Animal Farming
- (2007) M. M. L. van Rijen et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started